Today, we celebrate our latest cohort of Gilead interns. Our interns help shape innovation and possibilities through scientific advancement, diversity of thought and a commitment to creating a healthier world for all. We’re proud of them for pushing boundaries, embracing challenges and making a positive impact as emerging leaders in biopharma. #GileadLIfe
Gilead Sciences
Biotechnology Research
Foster City, CA 631,607 followers
Creating Possible
About us
At Gilead, we set – and achieve – bold ambitions to create a healthier world for all people. From our pioneering virology medicines to our growing impact in oncology, we're delivering innovations once thought impossible in medicine. Our focus goes beyond medicines, and we also strive to remedy health inequities and break down barriers to care. We empower our people to tackle these challenges, and we’re all united in our commitment to help millions of people live healthier lives. Social Media Guidelines: https://www.gilead.com/social-media-guidelines
- Website
-
http://www.gilead.com
External link for Gilead Sciences
- Industry
- Biotechnology Research
- Company size
- 10,001 employees
- Headquarters
- Foster City, CA
- Type
- Public Company
- Founded
- 1987
Locations
Employees at Gilead Sciences
Updates
-
Early diagnosis is essential to combating the #HIV epidemic, which is why Gilead partners with numerous organizations around the world to help ensure people are being tested and treated, especially in resource-limited areas. Learn about one such project, in Germany. https://gilead.inc/4fidZvQ #AIDS2024 | #PutPeopleFirst
-
#GileadNews: Research data presented at #AIDS2024 across our broad and innovative HIV treatment portfolio and pipeline reflect a focus to #PutPeopleFirst. Learn more about our efforts to help end the epidemic through scientific innovation: https://gilead.inc/4c13OJc
-
Our person-centric approach in HIV research prioritizes long-term studies and real-world evidence and considers the intersection of efficacy, adherence and resistance in #HIV treatment. Watch to learn more. #AIDS2024 | #PutPeopleFirst
-
#GileadNews: At #AIDS2024, we’re presenting new efficacy and safety data from the unprecedented PURPOSE 1 trial for our long-acting, investigational medication for HIV prevention. Learn more about our efforts as we move closer to ending the HIV epidemic: https://gilead.inc/4dclWB5
-
Today, we’re announcing a further five-year $25 million commitment to RADIAN, our collaboration with the Elton John AIDS Foundation to address the HIV crisis in Eastern Europe and Central Asia. Together, we can help end the epidemic. https://gilead.inc/46hVHqo
Gilead Sciences and EJAF announce a further five-year RADIAN partnership
-
With HIV diagnosis rates at approximately 90%, HIV experts in Germany united through a Gilead initiative to bridge the final gap. Watch the full video: https://gilead.inc/3We4oh5 #AIDS2024 | #PutPeopleFirst
Working Together to Help End the HIV Epidemic
-
We're committed to transformational collaborations at the global, national and local levels that aim to help address the diverse health needs and preferences of those affected by #HIV. Jared Baeten, SVP, Clinical Development, Virology, sat down with New Scientist to talk about Gilead’s commitment to person-centric innovation that extends beyond the lab. https://gilead.inc/4f5UOp4 #AIDS2024 | #PutPeopleFirst
Hear about the critical intersection of scientific innovation and health equity
-
For the fifth year, we’re on the Seramount 100 Best Companies list for our inclusive workplace and culture. Investing in our people can inspire a healthier and happier workforce that drives collaboration and impact. “Our people are our greatest asset and prioritizing their wellbeing is a cornerstone of Gilead’s culture. That’s why we continue to offer comprehensive benefits, create a supportive work environment and advocate for a healthy work-life balance,” says Jyoti Mehra, Executive Vice President, Human Resources. #Seramount100Best
-
#GileadNews: We’ll share data from our research and development programs and collaborations at #AIDS2024, underscoring our commitment to a person-centered approach to help advance progress toward ending the HIV epidemic. https://gilead.inc/3W4HGrE